Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1033202
Reference Type
Journal Article
Title
Paul Ehrlich: Pioneer of chemotherapy and cure by arsenic (1854-1915)
Author(s)
Thorburn, AL
Year
1983
Volume
59
Issue
6
Page Numbers
404-405
Language
English
PMID
6196079
DOI
10.1136/sti.59.6.404
Abstract
Paul Ehrlich's experiments in staining techniques at the end of the nineteenth century resulted in many discoveries which help to form the basis of present research work. Ehrlich's chemotherapy research led to his formulating the arsenic compound, Salvarsan, which was used in the treatment of syphilis during the first half of this century until it was superseded by penicillin.
Tags
IRIS
•
Arsenic (Inorganic)
1. Literature
PubMed
3. Hazard ID Screening
Other potentially supporting studies
•
Inorganic Arsenic (7440-38-2) [Final 2025]
1. Initial Lit Search
PubMed
4. Considered through Oct 2015
7. Other Studies through Oct 2015
Other
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity